Geovanny F Perez1, Krishna Pancham, Shehlanoor Huseni, Amisha Jain, Carlos E Rodriguez-Martinez, Diego Preciado, Mary C Rose, Gustavo Nino. 1. Division of Pulmonary and Sleep Medicine, Children's National Medical Center, Washington, DC, USA; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC, USA; Department of Integrative Systems Biology, George Washington University, Washington, DC, USA; Center for Genetic Research Medicine, Children's National Medical Center, Washington, DC, USA.
Abstract
BACKGROUND: Rhinovirus (RV) has been linked to the pathogenesis of asthma. Prematurity is a risk factor for severe RV infection in early life, but is unknown if RV elicits enhanced pro-asthmatic airway cytokine responses in premature infants. This study investigated whether young children born severely premature (<32 wks gestation) exhibit airway secretion of Th2 and Th17 cytokines during natural RV infections and whether RV-induced Th2-Th17 responses are linked to more respiratory morbidity in premature children during the first 2 yrs of life. METHODS: We measured Th2 and Th17 nasal airway cytokines in a retrospective cohort of young children aged 0-2 yrs with PCR-confirmed RV infection or non-detectable virus. Protein levels of IL-4, IL-13, TSLP, and IL-17 were determined with multiplex immunoassays. Demographic and clinical variables were obtained by electronic medical record (EMR) review. RESULTS: The study comprised 214 children born full term (n = 108), preterm (n = 44) or severely premature (n = 62). Natural RV infection in severely premature children was associated with elevated airway secretion of Th2 (IL-4 and IL-13) and Th17 (IL-17) cytokines, particularly in subjects with history of bronchopulmonary dysplasia. Severely premature children with high RV-induced airway IL-4 had recurrent respiratory hospitalizations (median 3.65 hosp/yr; IQR 2.8-4.8) and were more likely to have at least one pediatric intensive care unit admission during the first 2 yrs of life (OR 8.72; 95% CI 1.3-58.7; p = 0.02). CONCLUSIONS: Severely premature children have increased airway secretion of Th2 and Th17 cytokines during RV infections, which is associated with more respiratory morbidity in the first 2 yrs of life.
BACKGROUND: Rhinovirus (RV) has been linked to the pathogenesis of asthma. Prematurity is a risk factor for severe RV infection in early life, but is unknown if RV elicits enhanced pro-asthmatic airway cytokine responses in premature infants. This study investigated whether young children born severely premature (<32 wks gestation) exhibit airway secretion of Th2 and Th17 cytokines during natural RV infections and whether RV-induced Th2-Th17 responses are linked to more respiratory morbidity in premature children during the first 2 yrs of life. METHODS: We measured Th2 and Th17 nasal airway cytokines in a retrospective cohort of young children aged 0-2 yrs with PCR-confirmed RV infection or non-detectable virus. Protein levels of IL-4, IL-13, TSLP, and IL-17 were determined with multiplex immunoassays. Demographic and clinical variables were obtained by electronic medical record (EMR) review. RESULTS: The study comprised 214 children born full term (n = 108), preterm (n = 44) or severely premature (n = 62). Natural RV infection in severely premature children was associated with elevated airway secretion of Th2 (IL-4 and IL-13) and Th17 (IL-17) cytokines, particularly in subjects with history of bronchopulmonary dysplasia. Severely premature children with high RV-induced airway IL-4 had recurrent respiratory hospitalizations (median 3.65 hosp/yr; IQR 2.8-4.8) and were more likely to have at least one pediatric intensive care unit admission during the first 2 yrs of life (OR 8.72; 95% CI 1.3-58.7; p = 0.02). CONCLUSIONS: Severely premature children have increased airway secretion of Th2 and Th17 cytokines during RV infections, which is associated with more respiratory morbidity in the first 2 yrs of life.
Authors: Guillermina A Melendi; Federico R Laham; A Clara Monsalvo; Javier M Casellas; Victor Israele; Norberto R Polack; Steven R Kleeberger; Fernando P Polack Journal: Pediatrics Date: 2007-08 Impact factor: 7.124
Authors: E Kathryn Miller; Jimena Bugna; Romina Libster; Bryan E Shepherd; Paula M Scalzo; Patricio L Acosta; Diego Hijano; Natalia Reynoso; Juan P Batalle; Silvina Coviello; M Ines Klein; Gabriela Bauer; Alicia Benitez; Steven R Kleeberger; Fernando P Polack Journal: Pediatrics Date: 2011-12-26 Impact factor: 7.124
Authors: Dina Schneider; Jun Y Hong; Antonia P Popova; Emily R Bowman; Marisa J Linn; Alan M McLean; Ying Zhao; Joanne Sonstein; J Kelley Bentley; Jason B Weinberg; Nicholas W Lukacs; Jeffrey L Curtis; Uma S Sajjan; Marc B Hershenson Journal: J Immunol Date: 2012-02-13 Impact factor: 5.422
Authors: Geovanny F Perez; Krishna Pancham; Shehlanoor Huseni; Diego Preciado; Robert J Freishtat; Anamaris M Colberg-Poley; Eric P Hoffman; Mary C Rose; Gustavo Nino Journal: Eur Respir J Date: 2014-06-25 Impact factor: 16.671
Authors: Jun Young Hong; J Kelley Bentley; Yutein Chung; Jing Lei; Jessica M Steenrod; Qiang Chen; Uma S Sajjan; Marc B Hershenson Journal: J Allergy Clin Immunol Date: 2014-06-06 Impact factor: 10.793
Authors: T C Lewis; T A Henderson; A R Carpenter; I A Ramirez; C L McHenry; A M Goldsmith; X Ren; G B Mentz; B Mukherjee; T G Robins; T A Joiner; L S Mohammad; E R Nguyen; M A Burns; D T Burke; M B Hershenson Journal: Clin Exp Allergy Date: 2012-12 Impact factor: 5.018
Authors: Geovanny F Perez; Marcos Pérez-Losada; Natalia Isaza; Mary C Rose; Anamaris M Colberg-Poley; Gustavo Nino Journal: J Investig Med Date: 2017-03-31 Impact factor: 2.895
Authors: Lyndsey M Muehling; Peter W Heymann; Holliday Carper; Deborah D Murphy; Evan Rajadhyaksha; Joshua Kennedy; Stephen V Early; Manuel Soto-Quiros; Lydiana Avila; Lisa Workman; Thomas A E Platts-Mills; Judith A Woodfolk Journal: Clin Exp Allergy Date: 2022-06-06 Impact factor: 5.401
Authors: Xilei XuChen; Jered Weinstock; Maria Arroyo; Kyle Salka; Elizabeth Chorvinsky; Karima Abutaleb; Hector Aguilar; Ryan Kahanowitch; Carlos E Rodríguez-Martínez; Geovanny F Perez; Maria J Gutierrez; Gustavo Nino Journal: Front Pediatr Date: 2021-02-26 Impact factor: 3.418
Authors: Maria J Gutierrez; Jose L Gomez; Geovanny F Perez; Krishna Pancham; Stephanie Val; Dinesh K Pillai; Mamta Giri; Sarah Ferrante; Robert Freishtat; Mary C Rose; Diego Preciado; Gustavo Nino Journal: PLoS One Date: 2016-09-19 Impact factor: 3.240
Authors: Stephanie Val; Marian Poley; Kristy Brown; Rachel Choi; Stephanie Jeong; Annie Colberg-Poley; Mary C Rose; Karuna C Panchapakesan; Joe C Devaney; Marcos Perez-Losada; Diego Preciado Journal: PLoS One Date: 2016-04-14 Impact factor: 3.240